Post written by Kazuki Yamamoto, MD, PhD, from the Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan. This study introduces a novel therapeutic approach known as antireflux mucoplasty (ARM-P) to tackle the challenges associated with proton pump inhibitor (PPI)—refractory GERD. Previously, we pioneered 2 techniques, antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), which …
Tag: gastroesophageal reflux disease
Transoral incisionless fundoplication
Nikhil A. Kumta, MD from the Division of Gastroenterology and Hepatology at Weill Cornell Medical College in New York, New York, USA presents this video case, "Transoral incisionless fundoplication for treatment of refractory GERD after peroral endoscopic myotomy." Medical management of gastroesophageal reflux disease with proton pump inhibitors is effective in 70-80% of patients. For …
endoscopedia.com 